Horizon builds human disease models and reagents derived from genetically-engineered cells that its customers use, or that are deployed on their behalf to: gain knowledge of the genetic drivers of disease; develop novel drugs or cell therapies targeted.
Oxford Nanopore Technologies
19 followers
Abzena
2 followers
Neuralink
91 followers
Cytokinetics
21 followers
BridgeBio
14 followers
Beam
12 followers
Intellia Therapeutics
11 followers
Novotech
8 followers
Axsome Therapeutics
8 followers
Parkinson's UK
1 follower
Travere Therapeutics
6 followers
Squarepoint Capital
51 followers